SCHEMBL19981902

SCHEMBL19981902

Cc1c(C(=N)/C=C(/Nc2ccncn2)C(N)=O)ccc(F)c1NC(=O)c1cc2c(s1)CC(C)(C)C2O

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2465844 0.76 BTK (0.51) BTK
SCHEMBL19981742 0.71 MELK (0.34) BTK
SCHEMBL19981725 0.68 BTK (0.45) BTK
SCHEMBL19981932 0.67 CLK1 (0.38) BTK
SCHEMBL19981750 0.67 BTK (0.37) BTK
SCHEMBL19981969 0.67 HDAC3 (0.38) BTK
SCHEMBL19981492 0.67 BTK (0.38) BTK
SCHEMBL19981978 0.66 BTK (0.32) BTK
SCHEMBL19981562 0.65 SLC9A1 (0.36) BTK
SCHEMBL9984573 0.62 BTK (0.74) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365970-B1 PYRIDAZINONES AND THEIR USE AS BTK INHIBITORS GILEAD CONNECTICUT INC (US) 2018-03-21 EP disclosed